These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 22789049)
41. [The Working Group of Enforcement Officers (WGEO) : The European Network of Drug Regulatory Authorities to Combat Pharmaceutical Crime]. Wittstock M; Streit R Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1228-1232. PubMed ID: 28980025 [TBL] [Abstract][Full Text] [Related]
42. Fake medicines are undermining global efforts to combat infectious disease, says US journal. McCarthy M BMJ; 2015 Apr; 350():h2137. PubMed ID: 25899508 [No Abstract] [Full Text] [Related]
43. Combating poor-quality anti-malarial medicines: a call to action. Bassat Q; Tanner M; Guerin PJ; Stricker K; Hamed K Malar J; 2016 Jun; 15():302. PubMed ID: 27251199 [TBL] [Abstract][Full Text] [Related]
44. The global pandemic of falsified medicines: laboratory and field innovations and policy perspectives. Nayyar GML; Breman JG; Herrington JE Am J Trop Med Hyg; 2015 Jun; 92(6 Suppl):2-7. PubMed ID: 25897072 [No Abstract] [Full Text] [Related]
45. Tobacco control, global health policy and development: towards policy coherence in global governance. Collin J Tob Control; 2012 Mar; 21(2):274-80. PubMed ID: 22345267 [TBL] [Abstract][Full Text] [Related]
46. The primacy of public health considerations in defining poor quality medicines. Newton PN; Amin AA; Bird C; Passmore P; Dukes G; Tomson G; Simons B; Bate R; Guerin PJ; White NJ PLoS Med; 2011 Dec; 8(12):e1001139. PubMed ID: 22162953 [TBL] [Abstract][Full Text] [Related]
47. Graduated Sovereignty and Global Governance Gaps: Special Economic Zones and the Illicit Trade In Tobacco Products. Holden C Polit Geogr; 2017 Jul; 59():72-81. PubMed ID: 28674465 [TBL] [Abstract][Full Text] [Related]
48. Impact of the World Trade Organization TRIPS agreement on the pharmaceutical industry in Thailand. Supakankunti S; Janjaroen WS; Tangphao O; Ratanawijitrasin S; Kraipornsak P; Pradithavanij P Bull World Health Organ; 2001; 79(5):461-70. PubMed ID: 11417042 [TBL] [Abstract][Full Text] [Related]
49. [Counterfeit medicines: a growing threat]. Barbereau S Med Trop (Mars); 2006 Dec; 66(6):529-32. PubMed ID: 17286014 [TBL] [Abstract][Full Text] [Related]
50. Reducing the Power of the Alcohol Industry in Trade and Investment Agreement Negotiations Through Improved Global Governance of Alcohol Comment on "What Generates Attention to Health in Trade Policy-Making? Lessons From Success in Tobacco Control and Access to Medicines: A Qualitative Study of Australia and the (Comprehensive and Progressive) Trans-Pacific Partnership". O'Brien P Int J Health Policy Manag; 2022 Apr; 11(4):529-532. PubMed ID: 33619937 [TBL] [Abstract][Full Text] [Related]
51. Privatized Pharmaceutical Innovation vs Access to Essential Medicines: A Global Framework for Equitable Sharing of Benefits. Burci GL; Gostin LO JAMA; 2017 Feb; 317(5):473-474. PubMed ID: 28170485 [No Abstract] [Full Text] [Related]
52. The high price of "free" trade: U.S. trade agreements and access to medicines. Lopert R; Gleeson D J Law Med Ethics; 2013; 41(1):199-223. PubMed ID: 23581666 [TBL] [Abstract][Full Text] [Related]
53. Rethinking governance for trade and health. Walls H; Smith R BMJ; 2015 Jul; 351():h3652. PubMed ID: 26156072 [No Abstract] [Full Text] [Related]
54. Intellectual property rights, the World Trade Organization and public health: the Brazilian perspective. Viana JM Conn J Int Law; 2002; 17(2):311-8. PubMed ID: 12688298 [No Abstract] [Full Text] [Related]
55. WHO tries to tackle problem of counterfeit medicines in Asia. Pincock S BMJ; 2003 Nov; 327(7424):1126. PubMed ID: 14615319 [No Abstract] [Full Text] [Related]
56. Global constitutionalism, applied to global health governance: uncovering legitimacy deficits and suggesting remedies. Ooms G; Hammonds R Global Health; 2016 Dec; 12(1):84. PubMed ID: 27914471 [TBL] [Abstract][Full Text] [Related]
57. Impact on access to medicines from TRIPS-Plus: a case study of Thai-US FTA. Kessomboon N; Limpananont J; Kulsomboon V; Maleewong U; Eksaengsri A; Paothong P Southeast Asian J Trop Med Public Health; 2010 May; 41(3):667-77. PubMed ID: 20578557 [TBL] [Abstract][Full Text] [Related]
58. A Chilling Example? Uruguay, Philip Morris International, and WHO's Framework Convention on Tobacco Control. Russell A; Wainwright M; Mamudu H Med Anthropol Q; 2015 Jun; 29(2):256-77. PubMed ID: 25331730 [TBL] [Abstract][Full Text] [Related]
59. Trade, TRIPS, and pharmaceuticals. Smith RD; Correa C; Oh C Lancet; 2009 Feb; 373(9664):684-91. PubMed ID: 19167054 [TBL] [Abstract][Full Text] [Related]
60. Incorporating a right to health perspective into the resolution of patent law disputes. Oke EK Health Hum Rights; 2013 Dec; 15(2):97-109. PubMed ID: 24421172 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]